Supernus, Inc. (SUPN) stock
SUPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$29.04+0.21 (+0.73%)
Close on Nov 17, 2026Market cap $3.43BP/E 8.1Yield –
Supernus price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Supernus's price to sales ratio was 2.8× on Nov 11, 2026, against 3.6× a year earlier. Over the last 4 years it ranged from 1.0× to 4.7×, with a median of 2.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.8× | −1.0 |
| 2025 | Dec 31, 2025 | 3.9× | +2.3 |
| 2024 | Dec 31, 2024 | 1.6× | −0.8 |
| 2023 | Dec 29, 2023 | 2.4× | −1.8 |
| 2022 | Dec 30, 2022 | 4.2× | – |
See a number that looks wrong?